التفاصيل البيبلوغرافية
| العنوان: |
Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer? |
| المؤلفون: |
Haidong Huang, George Papatsibas, Paul Zarogoulidis, Vasilis Papadopoulos, Elena Maragouli |
| المصدر: |
Journal of Thoracic Disease. 9:2771-2773 |
| بيانات النشر: |
AME Publishing Company, 2017. |
| سنة النشر: |
2017 |
| مصطلحات موضوعية: |
0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Immune checkpoint inhibitors, medicine.disease_cause, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Growth factor receptor inhibitor, Epidermal growth factor receptor, Lung cancer, Mutation, integumentary system, biology, business.industry, Cancer, medicine.disease, respiratory tract diseases, Editorial, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Non small cell, business, Tyrosine kinase |
| الوصف: |
Tyrosine kinase inhibitors (TKIs) is the best treatment choice for patients with epidermal growth factor receptor mutation (EGFR) (1). |
| تدمد: |
2077-6624
2072-1439 |
| URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98c778566810972030b579b2cb42948
https://doi.org/10.21037/jtd.2017.08.24 |
| حقوق: |
OPEN |
| رقم الأكسشن: |
edsair.doi.dedup.....c98c778566810972030b579b2cb42948 |
| قاعدة البيانات: |
OpenAIRE |
